Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1961 1
1962 1
1972 2
1973 1
1974 1
1978 2
1980 1
1985 1
1994 1
1995 1
1996 3
1997 1
1999 2
2000 1
2001 1
2002 2
2003 1
2004 2
2005 1
2006 3
2007 4
2008 1
2009 6
2010 2
2011 6
2012 3
2013 4
2014 2
2015 2
2016 4
2017 2
2018 3
2019 4
2021 5
2022 3
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Results by year

Filters applied: . Clear all
Page 1
The IL13α 2R paves the way for anti-glioma nanotherapy.
Ulasov IV, Borovjagin A, Laevskaya A, Kamynina M, Timashev P, Cerchia L, Rozhkova EA. Ulasov IV, et al. Among authors: rozhkova ea. Genes Dis. 2021 Sep 15;10(1):89-100. doi: 10.1016/j.gendis.2021.08.006. eCollection 2023 Jan. Genes Dis. 2021. PMID: 37013057 Free PMC article. Review.
[Antioxidants].
Seĭfulla RD, Rozhkova EA, Kim EK. Seĭfulla RD, et al. Among authors: rozhkova ea. Eksp Klin Farmakol. 2009 May-Jun;72(3):60-4. Eksp Klin Farmakol. 2009. PMID: 19642595 Russian. No abstract available.
Intracellular gold nanoclusters boost energy conversion.
Chen Z, Rozhkova EA. Chen Z, et al. Among authors: rozhkova ea. Nat Nanotechnol. 2018 Oct;13(10):880-881. doi: 10.1038/s41565-018-0280-2. Nat Nanotechnol. 2018. PMID: 30275494 No abstract available.
Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial.
Halperin SA, Ye L, MacKinnon-Cameron D, Smith B, Cahn PE, Ruiz-Palacios GM, Ikram A, Lanas F, Lourdes Guerrero M, Muñoz Navarro SR, Sued O, Lioznov DA, Dzutseva V, Parveen G, Zhu F, Leppan L, Langley JM, Barreto L, Gou J, Zhu T; CanSino COVID-19 Global Efficacy Study Group. Halperin SA, et al. Lancet. 2022 Jan 15;399(10321):237-248. doi: 10.1016/S0140-6736(21)02753-7. Epub 2021 Dec 23. Lancet. 2022. PMID: 34953526 Free PMC article. Clinical Trial.
[Nanotechnology applications in pharmacology].
Seĭfulla RD, Timofeev AB, Ordzhonikidze ZG, Rozhkova EA, Kulikova EV, Druzhinin AE, Kuznetsov IuM, Kim EK. Seĭfulla RD, et al. Among authors: rozhkova ea. Eksp Klin Farmakol. 2008 Jan-Feb;71(1):61-9. Eksp Klin Farmakol. 2008. PMID: 18365491 Review. Russian.
81 results